Showing results (41-50 of 7,269) with videos related to
Sort By:
Pageof 727
Virus Research|December 3, 2014
Receptor-binding domain-based subunit vaccines against MERS-CoVNaru Zhang, Jian Tang, Lu Lu, et al.Vaccines|January 28, 2026
Omicron KP.3 RBD-Containing Spike mRNA Vaccine Induces Broadly Neutralizing Antibodies with Protection Against SARS-CoV-2 Omicron Infection in MiceXiaoqing Guan, Hansam Cho, Shengnan Qian, et al.Reviews in Medical Virology|September 19, 2012
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza virusesLanying Du, Ye Li, Jimin Gao, et al.Emerging Microbes & Infections|June 4, 2015
Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccinesShibo Jiang, Lu Lu, Qi Liu, et al.Cancer Letters|May 5, 2015
Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathwayTong Xiang, Lanying Du, Petra Pham, et al.International Journal of Molecular Sciences|May 27, 2026
Immunogenicity and Protection of mRNA Vaccine Encoding Spike Protein of SARS-CoV-2 Omicron-XEC SubvariantXiaoqing Guan, Hansam Cho, Qian Liu, et al.Journal of Thoracic Disease|August 27, 2013
Receptor-binding domain as a target for developing SARS vaccinesXiaojie Zhu, Qi Liu, Lanying Du, et al.Virology|October 18, 2016
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infectionWanbo Tai, Guangyu Zhao, Shihun Sun, et al.Plos Pathogens|November 26, 2024
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidateGang Ye, Fan Bu, Divyasha Saxena, et al.NPJ Vaccines|July 25, 2024
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoVGang Wang, Abhishek K Verma, Juan Shi, et al.Pageof 727